The New York Genome Center is a
501(c)(3) nonprofit academic research institution in
New York, New York. Since its inception, the center has raised over $500 million to support its genomic research, including federal and private grants and philanthropy. This includes two joint gifts from the
Simons Foundation and the Carson Family Charitable Trust; $100 million in 2016 and $125 million in 2019. The New York Genome Center also receives support from its member institutions, as well as New York State, the Empire State Development Corporation, the Partnership Fund for New York City, and the New York City Economic Development Corporation. Government funding has included a $55 million grant from New York State to support genomic medicine. In 2016 it received a $40 million grant from the
National Human Genome Research Institute to establish a Center for Common Disease Genomics, and is leading a collaborative, large-scale genomic sequencing program focused on advancing understanding of common diseases, including autism. Additionally, the Center and
Weill Cornell Medicine received a
National Cancer Institute grant to support a joint cancer genomics data center for the research and clinical interpretation of tumors, a part of the ongoing development of
The Cancer Genome Atlas. The center was also awarded a $13.5 million contract in 2015 to conduct whole genome sequencing and analysis for the
National Heart, Lung, and Blood Institute's TOPMed program. In 2017, New York State committed $17 million in capital improvements for the New York Genome Center to house JLABS@NYC, a life sciences incubator, which opened in summer 2018. == Notable faculty ==